Carlos Alfaro

Av. Pio XII 36
Pamplona, NC 31008, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Retraction: Blanca Alegría, Carlos Alfaro. Clinical grade adjuvants to mature CD141+ DCs for immunotherapy. Frontiers in Bioscience (Elite Edition). 2022; 14: 2.

Retraction: Blanca Alegría, Carlos Alfaro. Clinical grade adjuvants to mature CD141+ DCs for immunotherapy. Frontiers in Bioscience (Elite Edition). 2022; 14: 2.

Journal: Frontiers in bioscience (Elite edition)
Published: September 29, 2022

Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities.

Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities.

Journal: Cells
Published: January 20, 2022

Clinical grade adjuvants to mature CD141+ DCs for immunotherapy.

Clinical grade adjuvants to mature CD141+ DCs for immunotherapy.

Journal: Frontiers in bioscience (Elite edition)
Published: October 04, 2021

Implication of Interleukin Family in Cancer Pathogenesis and Treatment.

Implication of Interleukin Family in Cancer Pathogenesis and Treatment.

Journal: Cancers
Published: February 05, 2021

Significance of the IL-8 pathway for immunotherapy.

Significance of the IL-8 pathway for immunotherapy.

Journal: Human vaccines & immunotherapeutics
Published: December 21, 2019

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.

Journal: Immunity
Published: March 29, 2019

Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role?

Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role?

Journal: Journal of immunology research
Published: October 10, 2018

A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis.

A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis.

Journal: Journal for immunotherapy of cancer
Published: April 30, 2018

Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients.

Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2018

Interleukin-8 in cancer pathogenesis, treatment and follow-up.

Interleukin-8 in cancer pathogenesis, treatment and follow-up.

Journal: Cancer treatment reviews
Published: June 20, 2017

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 09, 2017

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 11, 2015
Showing 1-12 of 23

Last Updated: 09/26/2026